These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 22293986)

  • 1. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia.
    Brait VH; Arumugam TV; Drummond GR; Sobey CG
    J Cereb Blood Flow Metab; 2012 Apr; 32(4):598-611. PubMed ID: 22293986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the induction of inflammatory processes and infectious diseases in patients with ischemic stroke.
    Cieślak M; Wojtczak A; Cieślak M
    Acta Biochim Pol; 2013; 60(3):345-9. PubMed ID: 24046817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term T cell responses in the brain after an ischemic stroke.
    Selvaraj UM; Stowe AM
    Discov Med; 2017 Dec; 24(134):323-333. PubMed ID: 29373810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-stroke immunodeficiency: effects of sensitization and tolerization to brain antigens.
    Esmaeili A; Dadkhahfar S; Fadakar K; Rezaei N
    Int Rev Immunol; 2012 Oct; 31(5):396-409. PubMed ID: 23083348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.
    Dietel B; Cicha I; Achenbach S; Kollmar R; Garlichs C; Tauchi M
    Immunol Lett; 2014; 158(1-2):95-100. PubMed ID: 24333341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the hypothalamic-pituitary-adrenal (HPA) axis contributes to the immunosuppression of mice infected with Angiostrongylus cantonensis.
    Chen AL; Sun X; Wang W; Liu JF; Zeng X; Qiu JF; Liu XJ; Wang Y
    J Neuroinflammation; 2016 Oct; 13(1):266. PubMed ID: 27733201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking of α4 integrin does not protect from acute ischemic stroke in mice.
    Langhauser F; Kraft P; Göb E; Leinweber J; Schuhmann MK; Lorenz K; Gelderblom M; Bittner S; Meuth SG; Wiendl H; Magnus T; Kleinschnitz C
    Stroke; 2014 Jun; 45(6):1799-806. PubMed ID: 24743435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived antigens in lymphoid tissue of patients with acute stroke.
    Planas AM; Gómez-Choco M; Urra X; Gorina R; Caballero M; Chamorro Á
    J Immunol; 2012 Mar; 188(5):2156-63. PubMed ID: 22287710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T Cells and Cerebral Ischemic Stroke.
    Gu L; Jian Z; Stary C; Xiong X
    Neurochem Res; 2015 Sep; 40(9):1786-91. PubMed ID: 26220139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Involvement and Therapy Target of Immune Cells After Ischemic Stroke.
    Jian Z; Liu R; Zhu X; Smerin D; Zhong Y; Gu L; Fang W; Xiong X
    Front Immunol; 2019; 10():2167. PubMed ID: 31572378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Ischemia Induces Diversified Neuroantigen-Specific T-Cell Responses That Exacerbate Brain Injury.
    Jin WN; Gonzales R; Feng Y; Wood K; Chai Z; Dong JF; La Cava A; Shi FD; Liu Q
    Stroke; 2018 Jun; 49(6):1471-1478. PubMed ID: 29695462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to stroke: mechanisms, modulation, and therapeutic potential.
    Iadecola C; Buckwalter MS; Anrather J
    J Clin Invest; 2020 Jun; 130(6):2777-2788. PubMed ID: 32391806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental ischemic stroke induces long-term T cell activation in the brain.
    Xie L; Li W; Hersh J; Liu R; Yang SH
    J Cereb Blood Flow Metab; 2019 Nov; 39(11):2268-2276. PubMed ID: 30092705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation.
    Hurn PD; Subramanian S; Parker SM; Afentoulis ME; Kaler LJ; Vandenbark AA; Offner H
    J Cereb Blood Flow Metab; 2007 Nov; 27(11):1798-805. PubMed ID: 17392692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Yin and Yang of innate immunity in stroke.
    Xu X; Jiang Y
    Biomed Res Int; 2014; 2014():807978. PubMed ID: 24877133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting lymphocytes in ischemic stroke.
    Ducruet AF; Connolly ES
    World Neurosurg; 2011; 76(3-4):212-4. PubMed ID: 21986406
    [No Abstract]   [Full Text] [Related]  

  • 18. Adoptive regulatory T-cell therapy protects against cerebral ischemia.
    Li P; Gan Y; Sun BL; Zhang F; Lu B; Gao Y; Liang W; Thomson AW; Chen J; Hu X
    Ann Neurol; 2013 Sep; 74(3):458-71. PubMed ID: 23674483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral immune cells infiltrate into sites of secondary neurodegeneration after ischemic stroke.
    Jones KA; Maltby S; Plank MW; Kluge M; Nilsson M; Foster PS; Walker FR
    Brain Behav Immun; 2018 Jan; 67():299-307. PubMed ID: 28911981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular immune responses to ischemic brain injury.
    Seifert HA; Pennypacker KR
    Transl Stroke Res; 2014 Oct; 5(5):543-53. PubMed ID: 24895236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.